Clinical Epidemiology Division, Karolinska Institutet, Sweden
Disclosure information not submitted.
Comparative cardiovascular and renal effectiveness of empagliflozin and dapagliflozin: Scandinavian cohort study
Wednesday, August 28, 20249:30 AM – 9:45 AM CEST